• SENSEX 74,660.02
    -121.74 (--0.16%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • HDFC Bank
    730.30 1,020.35(%)
  • Raymond
    1,121.80 1,024.00(%)
  • Solar Industries
    19,450.15 11,641.10(%)
  • Zensar Tech.
    479.80 868.50(%)
  • Infosys
    1,097.40 1,727.85(%)
  • Tata Inv.Corpn.
    750.30 1,184.00(%)
  • ESDS Software
    1,802.15 1,716.35(%)
  • TCS
    2,322.50 3,336.70(%)
  • Pine Labs
    191.50 134.75(%)
  • Reliance Industries
    1,249.00 1,250.55(%)
  • Hero Motocorp
    5,325.55 6,390.00(%)
  • Netweb Technol.
    4,682.85 2,820.80(%)
  • Gland Pharma
    2,882.00 1,575.00(%)
  • Bharat Electron
    387.65 380.35(%)
  • Afcons Infrastr.
    304.70 479.05(%)
  • HCL Technologies
    1,290.10 1,770.00(%)
  • Coforge
    1,784.00 1,008.50(%)
  • SBI
    979.80 816.25(%)
  • IFCI
    78.12 46.20(%)
  • Piramal Finance.
    2,236.40 1,235.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Par Drugs & Chemicals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 66408.0
  • ISIN : INE04LG01015
140.92 0 (-0.11%)
  • As on 15 Sep 2026 (EOD)

  • Today’s Low

    134.03

  • Today’s High

    147.96

  • Open

    141.99

  • Perv Close

    141.08

  • 52W Low

    78.05

  • 52W High

    180.00

Key Indicators

  • P/E(TTM)

    11.96

  • Mar.Cap (₹Cr.)

    173.40

  • Div & Yield %

    0.00

  • Book Value(₹)

    91.01

  • Debt-Equity Ratio

    -0.11

  • AGM Date

    11-Sep-2026

  • EPS

    11.78

  • P/E Ratio

    11.96

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    173.40

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    12.30

  • BV (₹)

    91.00

  • Sales( ₹ in Cr.)

    103.66

  • NP (in Cr.)

    10.50

  • NP Var(%)

    -13.0

  • Div%

    0.0

  • CPS (₹)

    11.50

  • EPS (₹)

    8.50

  • Traded Value (₹ in Lakhs)

    173.40

  • 52 Week High

    180.00

  • 52 Week Low

    78.05

  • Price BSE

    0.0

  • Price NSE

    141.00

  • Market Capital( in Cr.)

    173.40

  • P/C Ratio

    12.20

  • P/E Ratio

    16.50

  • Price Vs.BV

    8.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 116.28 113.39 107.26 95.75 84.85 69.07
Excise Duty 12.63 12.42 11.62 0.00 9.78 8.32
Net Sales 103.65 100.97 95.64 95.75 75.07 60.75
Other Income 4.00 2.15 0.24 0.24 0.18 2.18
Stock Adjustments -0.69 1.28 -0.47 0.70 0.79 0.21
Total Income 106.96 104.40 95.41 96.69 76.04 63.14
EXPENDITURE :            
Raw Materials 42.67 39.41 33.32 41.03 29.61 22.09
Power and Fuel Cost 18.66 19.49 16.40 17.83 13.49 9.82
Employee Cost 6.12 5.85 5.50 4.89 4.10 3.98
Other Manufacturing Expenses 6.18 6.01 5.57 4.68 4.02 3.43
Selling and Administration Expenses 11.85 11.63 10.16 9.60 8.22 5.62
Miscellaneous Expenses 0.36 0.36 1.40 0.22 0.16 0.01
Employee Benefit Expenses 6.12 5.85 5.50 4.89 4.10 3.98
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 85.83 82.75 72.35 78.25 59.61 44.95
Operating Profit 21.13 21.65 23.06 18.44 16.43 18.19
Interest 0.13 0.08 0.11 0.13 0.45 0.64
Gross Profit 21.00 21.57 22.95 18.31 15.98 17.55
Depreciation 3.70 3.65 3.44 3.23 3.28 2.82
Profit Before Tax 17.30 17.92 19.51 15.08 12.70 14.73
Current Tax 4.53 4.53 4.98 3.80 3.35 3.36
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.34 0.04 0.04 -0.05 0.14 -0.25
Reported Net Profit 13.11 13.36 14.50 11.33 9.21 11.61
Extraordinary Items 2.61 1.33 0.01 0.11 0.00 1.53
Adjusted Net Profit 10.50 12.03 14.49 11.22 9.21 10.08
Adjustment below Net Profit -0.10 -0.02 -0.11 0.03 -0.01 -0.01
P & L Balance brought forward 75.89 62.55 48.16 36.80 29.13 17.53
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 1.54 0.00
P & L Balance carried down 88.90 75.89 62.55 48.16 36.80 29.13
Dividend 0.00 0.00 0.00 0.00 1.54 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 10.65 10.86 11.79 9.21 7.49 18.87
Earnings Per Share(Adj)-Unit Curr 10.65 10.86 11.79 9.21 7.49 9.44
Book Value 91.01 80.44 69.59 57.90 48.66 84.87
Book Value(Adj)-Unit Curr 91.01 80.44 69.59 57.90 48.66 42.44

Shareholding Pattern

  • Promoter Group

    73.41%

  • Public Share Holding

    26.59%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,032,750 73.41 9,032,750 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,032,750 73.41 9,032,750 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 10,465 0.09 10,465 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10,465 0.09 10,465 1
2] Non Institution
Bodies Corporate 400,604 3.26 400,604 26
Clearing Members 912 0.01 912 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 131,554 1.07 131,554 124
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 152,087 1.24 152,087 176
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 166,769 1.36 166,769 5
Individuals holding nominal share capital up to Rs. 1 lakh 2,287,553 18.59 2,287,553 12,436
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,261,421 26.51 3,261,421 12,775
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,304,636 100.00 12,304,636 12,782

Company Background

Par Drugs & Chemicals LtdPharmaceuticals - Indian - Bulk Drugs

  • Par Drugs & Chemicals Ltd
  • BSE Code : 66408.0
  • ISIN : INE04LG01015

  • Incorporation Year

    1999

  • Registered Office

    805 Dwarkesh Complex
    RC Dutt Road Alkapuri, Vadodara,
    Gujarat-390007

  • Telephone

    91-265-2332018

  • FAX

  • Chairman

    FALGUN VALLABHBHAI SAVANI

  • Managing Director

  • Company Secretary

    Sanket Bhupendrabhai Trivedi

  • Auditor

    Sarupriya Somani & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Par Drugs & Chemicals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Par Drugs & Che. 140.92 107.66 116.28 11.96 14.53
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77